Genjiro Kusano
Osaka University of Pharmaceutical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Genjiro Kusano.
Phytochemistry | 1993
Jian Feng Ma; Genjiro Kusano; Syojiro Kimura; Kyosuke Nomoto
Abstract The uptake rate by iron-deficient barley roots ( Hordeum vulgare , cv Minorimugi) from mugineic acid complexed with Fe(III) was much higher than corr
Phytochemistry | 1998
Masayukui Takahira; Akiko Kusano; Makio Shibano; Genjiro Kusano; Toshio Miyase
Abstract Investigation of the underground parts of Cimicifuga simplex afforded five new piscidic acid esters and two new fukiic acid esters: 2-caffeoyl piscidic acid, 2-feruloyl piscidic acid, 2-isoferuloyl piscidic acid, 2-feruloyl piscidic acid-1-methyl ester, 2-isoferuloyl piscidic acid-1-methyl ester, 2-feruloyl fukiic acid-1-methyl ester, and 2-isoferuloyl fukiic acid-1-methyl ester.
European Journal of Pharmaceutical Sciences | 2009
Ayako Yawata; Yuko Matsuhashi; Hanako Kato; Keiko Uemura; Genjiro Kusano; Junko Ito; Toshiyuki Chikuma; Hiroshi Hojo
Cimicifugoside, a triterpenoid isolated from Cimicifuga simplex, which has been used as a traditional Chinese medicine due to its anti-inflammatory, analgesic or anti-pyretic action, was examined for inhibition of nucleoside transport and synergistic potentiation of methotrexate cytotoxicity. Cimicifugoside inhibited uptake of uridine, thymidine and adenosine in human leukemia U937 cells with the low nanomolar IC(50) values, but did not affect that of uracil, leucine or 2-deoxyglucose at <or=100 nM. Cimicifugoside analogs differentially inhibited uridine uptake in the order cimicifugoside>cimicifugenin (aglycon of cimicifugoside)>bugbanoside B>cimicifugenin A, O-methyl cimicifugenin and bugbanoside A. Cimicifugoside had less affinity for the binding site of nitrobenzylthioinosine (typical high-affinity inhibitor of equilibrative nucleoside transporter-1) in U937 cells, K562 cells and human erythrocyte membranes compared with the prototype nucleoside transport inhibitor dipyridamole. Cimicifugoside markedly potentiated methotrexate cytotoxicity in a culture of U937 cells and human carcinoma KB cells. Potentiation of methotrexate cytotoxicity by cimicifugoside analogs in U937 cells was in proportion to their inhibitory activity against uridine uptake. The present study demonstrates that cimicifugoside is a novel specific nucleoside transport inhibitor that displays synergistic potentiation of methotrexate cytotoxicity.
Chemical & Pharmaceutical Bulletin | 2001
Makio Shibano; Daisuke Tsukamoto; Atsuko Masuda; Yasuko Tanaka; Genjiro Kusano
Chemical & Pharmaceutical Bulletin | 1997
Makio Shibano; Satoshi Kitagawa; Satoko Nakamura; Naomi Akazawa; Genjiro Kusano
Chemical & Pharmaceutical Bulletin | 1997
Makio Shibano; Satoshi Kitagawa; Genjiro Kusano
Biological & Pharmaceutical Bulletin | 2000
Hiroaki Hayashi; Noriko Hosono; Mieko Kondo; Noboru Hiraoka; Yasumasa Ikeshiro; Makio Shibano; Genjiro Kusano; Hirobumi Yamamoto; Toshihito Tanaka; Kenichiro Inoue
Chemical & Pharmaceutical Bulletin | 1998
Makio Shibano; Daisuke Tsukamoto; Rie Fujimoto; Yasue Masui; Hisako Sugimoto; Genjiro Kusano
Biological & Pharmaceutical Bulletin | 1998
Mariko Noguchi; Masahiro Nagai; Mamoru Koeda; Shigeki Nakayama; Nobuko Sakurai; Masayuki Takahira; Genjiro Kusano
Chemical & Pharmaceutical Bulletin | 1998
Akiko Kusano; Masayuki Takahira; Makio Shibano; Yasuko In; Toshimasa Ishida; Toshio Miyase; Genjiro Kusano